Skip Nav Destination
1-1 of 1
Development (2003) 130 (10): 2083–2093.
Published: 15 May 2003
... that exhibits retinoic acid receptor β (RARβ) agonistic properties in transfected cells. By contrast, no branchial arch defects are observed following treatment with synthetic retinoids that exhibit RARα or RARγ agonistic properties. The BMS453-induced branchial arch defects are mediated through RAR activation...